Debt, Deficits & Disaster: The Bond Market Crisis
Not Wall Street, But AI: The Real Force Democratizing Finance Across America
When Flooding Pays: A New Financial Bet
Breakfast for Life How Local Diners and Hardware Stores are Outsmarting Amazon
Fundamentals for CME Group Inc.
Business Operations:
Sector: Financial ServicesIndustry: Financial Data & Stock Exchanges
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Revenue projections:
Investors may react cautiously to news that CME's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.
Financial Ratios:
| currentRatio | 1.018000 |
|---|---|
| forwardPE | 22.323538 |
| debtToEquity | 14.059000 |
| earningsGrowth | 0.213000 |
| revenueGrowth | 0.144000 |
| grossMargins | 1.000000 |
| operatingMargins | 0.698060 |
| trailingEps | 11.720000 |
| forwardEps | 12.868480 |
CME Group Inc.'s current ratio of 1.018 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. CME Group Inc.'s ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
CME's Forward PE ratio is in a good range, reflecting a reasonable balance between stock price and earnings. The stock is not overpriced, leaving room for growth, which suggests potential for investors looking to capitalize on future value appreciation.
CME's Debt-to-Equity ratio is low, indicating the company is not over-leveraged. This suggests a prudent approach to financing, with minimal dependence on debt, reducing the financial risk associated with high leverage, and signaling a stable financial outlook.
With earnings and revenue growth in positive territory, CME is projected to expand its business. This strong financial performance suggests the company will continue to grow, as increased profitability and sales drive future success.
Positive gross and operating margins for CME suggest that the company is operating profitably. These margins highlight CME's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
With CME's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in CME's growth potential, as improved earnings are forecasted compared to the prior year's performance.
Price projections:
CME's price has often been near the lower end of the projected range. This ongoing trend suggests that investor confidence might be waning, and the stock could face challenges in gaining upward momentum.
Insider Transactions:
25 CME transactions were recorded, when the market price was 278.18439697265626.CME saw 3 buying transactions, each while market price hovered at 277.7766621907552.CME Group Inc.'s current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.
Recommendation changes over time:
CME has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view CME as a reliable choice for their money, offering a promising avenue for future growth and financial gains.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
Before They Can Walk, They're Invested: How Trump Accounts Are Transforming Financial Culture
The Appalachian Energy Reboot: Inside the Unexpected Nuclear Startup Boom
Theatrical Finance: Credit Unions Use Drama to Attract Youth